- Home
- IXHL vs CVM Comparison
IXHL vs CVM Comparison
Compare IXHL & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- CVM
- Stock Information
- Founded
- IXHL 2001
- CVM 1983
- Country
- IXHL Australia
- CVM United States
- Employees
- IXHL N/A
- CVM N/A
- Industry
- IXHL
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IXHL
- CVM Health Care
- Exchange
- IXHL Nasdaq
- CVM Nasdaq
- Market Cap
- IXHL 39.2M
- CVM 40.1M
- IPO Year
- IXHL N/A
- CVM 1987
- Fundamental
- Price
- IXHL $1.93
- CVM $0.40
- Analyst Decision
- IXHL
- CVM
- Analyst Count
- IXHL 0
- CVM 0
- Target Price
- IXHL N/A
- CVM N/A
- AVG Volume (30 Days)
- IXHL 24.2K
- CVM 2.0M
- Earning Date
- IXHL 11-14-2024
- CVM 01-13-2025
- Dividend Yield
- IXHL N/A
- CVM N/A
- EPS Growth
- IXHL N/A
- CVM N/A
- EPS
- IXHL N/A
- CVM N/A
- Revenue
- IXHL $86,000.00
- CVM N/A
- Revenue This Year
- IXHL $3,817.06
- CVM N/A
- Revenue Next Year
- IXHL $66.67
- CVM $152.91
- P/E Ratio
- IXHL N/A
- CVM N/A
- Revenue Growth
- IXHL N/A
- CVM N/A
- 52 Week Low
- IXHL $1.50
- CVM $0.36
- 52 Week High
- IXHL $8.47
- CVM $3.08
- Technical
- Relative Strength Index (RSI)
- IXHL 52.16
- CVM 38.00
- Support Level
- IXHL $1.71
- CVM $0.37
- Resistance Level
- IXHL $2.19
- CVM $0.42
- Average True Range (ATR)
- IXHL 0.16
- CVM 0.04
- MACD
- IXHL -0.00
- CVM -0.00
- Stochastic Oscillator
- IXHL 41.12
- CVM 11.83
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.